DSCAM and ductal breast carcinoma in situ: This may explain why DSCAM-AS1, albeit clearly associated to neoplastic growth, is very high in ductal carcinoma in situ, whereas its expression may be reduced when cells escape cell-to-cell contacts, undergo EMT and acquire invasiveness.